Clinical/scientific notes

Neurology

Volumn 79, Issue 10, 2012, Pages 1065-1066

  Jacob, Anu ^a   Hutchinson, Michael ^b   Elsone, Liene ^a   Kelly, Siobhan ^b   Ali, Rehiana ^a   Saukans, Ivars ^c   Tubridy, Niall ^b   Boggild, Mike ^a  

^a THE WALTON CENTRE NHS FOUNDATION TRUST   (United Kingdom)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^c RIGA EAST UNIVERSITY HOSPITAL   (Latvia)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 4 ANTIBODY; BETA1A INTERFERON; CORTICOSTEROID; GLATIRAMER; INTERFERON BETA SERINE; MITOXANTRONE; NATALIZUMAB; PREDNISOLONE; RITUXIMAB; MONOCLONAL ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; BRAIN ATROPHY; BRAIN DAMAGE; CASE REPORT; CORPUS CALLOSUM; DIPLOPIA; DISEASE ACTIVITY; DISEASE EXACERBATION; DROWSINESS; FATIGUE; FEMALE; HAND PARESTHESIA; HEMIANOPIA; HEMIPARESIS; HUMAN; LEUKOCYTE COUNT; LEUKOMALACIA; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC DISK; OPTIC NEURITIS; PALLOR; PARESTHESIA; PLASMAPHERESIS; PNEUMONIA; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; QUADRIPLEGIA; RELAPSE; URINE RETENTION; VISUAL IMPAIRMENT; WEAKNESS; BRAIN; DISEASE COURSE; MYELINATED NERVE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; BRAIN; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MULTIPLE SCLEROSIS; NERVE FIBERS, MYELINATED; NEUROMYELITIS OPTICA;

EID: 84866054959     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31826845fe     Document Type: Article

References (6)

1. Barnett M, Prineas J, Buckland M, Parratt J, Pollard J. Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapy. Mult Scler Epub 2011.
2. Kleiter I, Hellwig K, Berthele A, et al. Failure of natalizumab to prevent relapses in neuromyelitis optica. Arch Neurol 2012;69:239-245.
3. Krumbholz M, Meinl I, Kumpfel T, Hohlfeld R, Meinl E. Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis. Neurology 2008;71:1350-1354.
4. Stuve O, Marra CM, Bar-Or A, et al. Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumabtreated patients with multiple sclerosis. Arch Neurol 2006;63:1383-1387.
5. Stenner MP, Waschbisch A, Buck D, et al. Effects of natalizumab treatment on Foxp3+ T regulatory cells. PLoS One 2008;3:e3319.
6. Palace J, Leite MI, Nairne A, Vincent A. Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers. Arch Neurol 2010;67:1016-1017.